Lv11
90 积分 2026-03-03 加入
NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025
1个月前
已完结
Sustained Complete Remission with Incomplete Hematologic Recovery (CRi) in a Patient with Relapsed AML and Concurrent BCR-ABL1 and CBFB Rearrangement Treated with a Combination of Venetoclax and 5-Azacytidine
1个月前
已完结
A CEBPB/IL-1β/TNF-α feedback loop drives drug resistance to venetoclax and MDM2 inhibitors in monocytic leukemia
2个月前
已完结
皖公网安备34019202002308
